Table 1 Baseline and demographic characteristics

Sex (male), n/total (%)

8/15 (53.3)

4/14 (28.6)

0.1761

Age (years), median (IQR)

29.0 (27.0–37.0)

34.5 (25.0–38.7)

0.7100

BMI, median (IQR)

22.1 (20.7–23.9)

49.3 (43.5–50.6)

< 0.0001

Physical activity, n/total (%)

0/15 (0)

0/14 (0)

–

Comorbidities, n/total (%)

 Type 2 Diabetes mellitus

0/15 (0)

1/14 (7.14)

–

 Dyslipidemia

0/15 (0)

4/14 (28.6)

–

 Hepatic Steatosis

0/15 (0)

6/14 (42.8)

–

 Hypertension

0/15 (0)

7/14 (50.0)

–

 Metabolic Syndrome

0/15 (0)

0/14 (0)

–

Medication therapy

 ACE Inhibitors (ACEI)

0/15 (0)

3/14 (21.43)

–

 Angiotensin II receptor blockers

0/15 (0)

1/14 (7.14)

–

 Calcium channel blockers

0/15 (0)

1/14 (7.14)

–

 Loop diuretics

0/15 (0)

2/14 (14.28)

–

 Statin

0/15 (0)

1/14 (7.14)

–

 Selective beta-blockers

0/15 (0)

3/14 (21.43)

–

 Thiazide diuretics

0/15 (0)

2/14 (14.28)

–